|
Name |
pyrrospirone F
|
| Molecular Formula | C32H43NO5 | |
| IUPAC Name* |
7-hydroxy-17-(1-hydroxyethyl)-12,14,16,19,21-pentamethyl-2-oxa-6-azahexacyclo[12.9.2.13,7.15,9.011,24.018,23]hexacosa-1(22),14,19,25-tetraene-4,8-dione
|
|
| SMILES |
CC1=CC(C)(C(C)O)C2C(=O)C3CC(O)(Cc4ccc(cc4)OC4C2C1C1(C)CC(C)CC(C)C41)NC3=O
|
|
| InChI |
InChI=1S/C32H43NO5/c1-16-11-17(2)25-28-23-24(31(25,6)12-16)18(3)13-30(5,19(4)34)26(23)27(35)22-15-32(37,33-29(22)36)14-20-7-9-21(38-28)10-8-20/h7-10,13,16-17,19,22-26,28,34,37H,11-12,14-15H2,1-6H3,(H,33,36)/t16-,17+,19+,22-,23+,24-,25+,26+,28+,30-,31+,32-/m1/s1
|
|
| InChIKey |
YDVFTOUQAGTCHM-NRLNSIIISA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 521.7 | ALogp: | 4.3 |
| HBD: | 3 | HBA: | 5 |
| Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
| Polar Surface Area: | 95.9 | Aromatic Rings: | 7 |
| Heavy Atoms: | 38 | QED Weighted: | 0.363 |
| Caco-2 Permeability: | -4.923 | MDCK Permeability: | 0.00011937 |
| Pgp-inhibitor: | 0.828 | Pgp-substrate: | 0.259 |
| Human Intestinal Absorption (HIA): | 0.024 | 20% Bioavailability (F20%): | 0.013 |
| 30% Bioavailability (F30%): | 0.013 |
| Blood-Brain-Barrier Penetration (BBB): | 0.588 | Plasma Protein Binding (PPB): | 94.50% |
| Volume Distribution (VD): | 1.958 | Fu: | 2.95% |
| CYP1A2-inhibitor: | 0.02 | CYP1A2-substrate: | 0.838 |
| CYP2C19-inhibitor: | 0.282 | CYP2C19-substrate: | 0.93 |
| CYP2C9-inhibitor: | 0.32 | CYP2C9-substrate: | 0.182 |
| CYP2D6-inhibitor: | 0.018 | CYP2D6-substrate: | 0.344 |
| CYP3A4-inhibitor: | 0.865 | CYP3A4-substrate: | 0.794 |
| Clearance (CL): | 16.386 | Half-life (T1/2): | 0.027 |
| hERG Blockers: | 0.179 | Human Hepatotoxicity (H-HT): | 0.589 |
| Drug-inuced Liver Injury (DILI): | 0.804 | AMES Toxicity: | 0.005 |
| Rat Oral Acute Toxicity: | 0.996 | Maximum Recommended Daily Dose: | 0.926 |
| Skin Sensitization: | 0.026 | Carcinogencity: | 0.024 |
| Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
| Respiratory Toxicity: | 0.93 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC004853 | ![]() |
0.823 | D0W2EK | ![]() |
0.238 | ||
| ENC003349 | ![]() |
0.714 | D0E9KA | ![]() |
0.232 | ||
| ENC003851 | ![]() |
0.685 | D0I5DS | ![]() |
0.229 | ||
| ENC003989 | ![]() |
0.620 | D0F1EX | ![]() |
0.226 | ||
| ENC005320 | ![]() |
0.617 | D05VQI | ![]() |
0.223 | ||
| ENC003503 | ![]() |
0.585 | D0V4WD | ![]() |
0.222 | ||
| ENC003137 | ![]() |
0.569 | D0D2TN | ![]() |
0.221 | ||
| ENC005770 | ![]() |
0.504 | D0CZ1Q | ![]() |
0.221 | ||
| ENC003606 | ![]() |
0.453 | D08PIQ | ![]() |
0.221 | ||
| ENC005366 | ![]() |
0.453 | D03IKT | ![]() |
0.218 | ||